Member Info for Mikey279

lol its gonna go to £5+ and i'm genuinely ****ed that i could've had so much more!!

got to admit i sliced some into IHC as that will move the same soon IMO... so kind of ****ed but not really

if the figures are monstrous its gonna open up 100%.... christ

if you're out... its alright no one could've called a tie up with a 5bn company, so you probably did the right thing at the time

ah the moment this becomes a £300m company and just sits there has finally come

traders who are transparent as **** talking **** when out and pumping when in...... suck on that ;)

IMO

ah wasn't lying about £5- £10 ;)

5bn mcap lol.

as with NCYT the number of tests needed was a guarantee, the same apply to ventilators - there will be a shortage globally, as for sourcing supplies etc, there'd no doubt be a lifting of restrictions to meet the global demand, it's a certainty IMO

Mcap is a currently a total joke to reflect on the current situation

additional £1*, previously at 60p ish - after recording double digit revenue growth and positive £2m EBITDA - it was undervalued already due to Lombard

well the latest contracts should add circa £2.6m to the bottom line if you P/E that at a conservative 10-15- should be a £1 on the SP
Excludes all future potential income/arrangements too, now that there's exposure to the NHS/corona crisis and global demand/consortium

It will re-rate before next news IMO

folks bailing way too soon IMO, only just begun

Freefloat here is non-existent it'll brush through 10p at a time in minutes lol

called it..... £1.50 - £2 at least

Just did some further research, solid little company that hasn't had much publicity, looks like Lombard were exiting hence the range - but £5.25m worth of NHS ventilator orders will do it a world of good at only £27m mcap - should at the very least double now that the momentum and blackswan event is here IMO

An important RNS that's not on LSE but found on the company website dated 20/2/19 - double digit revenue growth circa 18m and 2m EBITDA, CEO and commercial director hold 20% between them, the rest II's and other large holders, very low freefloat

Recently placed to fund an acquisition, of which directors took part at 59.5p

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, is pleased to announce a trading update for the year ended 31 January 2020. The Company has performed ahead of expectations and anticipates reporting a 15% increase in Group revenue over the prior financial year to approximately £17.8m, including revenue from the recently acquired Viomedex business, or growth of 12% on a like for like basis. EBITDA1 is expected to be between the range of £2.0 to £2.1m, representing growth of more than 20% over the previous financial year.

Strong balance sheet and net asset position, cashed up, no debt and no warrants as far as I'm aware

They operate at around 50% margins and have a global as well as domestic arm - so it should roughly be another 2.5m straight to the bottom line, you'd imagine there'd be many other requests globally at this point in time

All IMO

DYOR

almost certain they're flushed out now....they're a solid growing business even without COVID 19, another black swan event

29m mcap

Got in at NCYT at 47p, convinced of something similar here, with half the amount of shares in issue

DYOR all IMO

you'd imagine there be an RNS of some sort on the consortium too, not sure how they'd work but at the very least some profit share/royalty fees if they're standardising a ventilator

for peanuts

yup... 600k shares as of yesterday looks really close now

Should IMO be nearer to £1.50-£2 without consideration of further contracts

See my notes from last night

DYOR

lovely, another company to hold in these challenging times along with IHC/NCYT